◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Medico Remedies Limited (MEDICO) Financial History

Name: Medico Remedies Limited (MEDICO) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-10-22

Medico Remedies Limited (MEDICO) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 105 employees. Its market capitalization is roughly ₹2 billion. In the fiscal year ended 2026-03-31, MEDICO reported ₹2.0B in revenue and ₹131M in net income.

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India.

Interactive charts & full statements → Open the MEDICO valuation workbench →

MEDICO Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹2.4B	₹2.0B	₹1.5B	₹1.4B	₹1.4B	—
Gross Profit	₹578M	₹380M	₹296M	₹247M	₹258M	—
Operating Income (EBIT)	₹144M	₹139M	₹120M	₹100M	₹69M	—
Net Income	₹138M	₹131M	₹101M	₹83M	₹72M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MEDICO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹694M	₹568M	₹587M	₹526M	₹382M	—
Gross Profit	₹136M	₹174M	₹146M	₹122M	₹109M	—
Operating Income (EBIT)	₹26M	₹64M	₹35M	₹20M	₹21M	—
Net Income	₹25M	₹59M	₹29M	₹26M	₹18M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MEDICO Free Cash Flow History

MEDICO Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹1.5B	₹1.2B	₹962M	₹874M	—
Total Liabilities	₹779M	₹573M	₹438M	₹436M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MEDICO viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

AMBALALSA · Ambalal Sarabhai Enterprises Limited — ₹3 billion
NECLIFE · Nectar Lifesciences Limited — ₹2 billion
DMP · Dermapharm Holding SE — €2 billion
BROOKS · Brooks Laboratories Limited — ₹2 billion
NATCAPSUQ · Natural Capsules Limited — ₹2 billion
6896 · Golden Throat Holdings Group Company Limited — HK$1 billion
2348 · Dawnrays Pharmaceutical (Holdings) Limited — HK$1 billion
PPGN · PolyPeptide Group AG — CHF 1 billion

← MEDICAPQ All “M” companies MEDN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.